The European Pharmacogenomics Clinical Implementation Project (U-PGx) performed a survey about pharmacogenomic knowledge among 70 healthcare professionals in 2017. Of participants, 84,3% found pharmacogenomics relevant to their current practice, but experience was still rare. Two-thirds (65,7%) did not order nor recommend a pharmacogenomic test during the past year. This was mainly attributed to lack of sufficient knowledge about pharmacogenomics (40%).
Needs were identified in application of pharmacogenomics: Identifying drugs (41.4%) and interpreting test results (37.2%) as well as underlying mechanisms as better knowledge on drug metabolism (67.1%), better knowledge of basic principles of pharmacogenomics (60.0%). The study analysed the specific attitudes, experience and education regarding pharmacogenomics of future users. There was a generally positive attitude towards pharmacogenomic testing. However, the level of personal experience, and lack of knowledge about application and interpretation of pharmacogenomics caused uncertainty. Thus, education and training programmes may be helpful for implementation of pharmacogenomics at a homogenous level within Europe.
On-line version of the U-PGx study by Susanne Just et al.: doi:10.1007/s00228-017-2292-5